Kyle Guse
2017
In 2017, Kyle Guse earned a total compensation of $735.7K as Chief Financial Officer, General Counsel and Secretary at Atossa Genetics, a 6% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $163,800 |
|---|---|
| Option Awards | $195,919 |
| Salary | $364,000 |
| Other | $12,000 |
| Total | $735,719 |
Guse received $364K in salary, accounting for 49% of the total pay in 2017.
Guse also received $163.8K in non-equity incentive plan, $195.9K in option awards and $12K in other compensation.
Rankings
In 2017, Kyle Guse's compensation ranked 10,390th out of 14,666 executives tracked by ExecPay. In other words, Guse earned more than 29.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,390 out of 14,666 | 29th |
Division Manufacturing | 4,026 out of 5,768 | 30th |
Major group Chemicals And Allied Products | 1,423 out of 2,074 | 31st |
Industry group Drugs | 1,158 out of 1,730 | 33rd |
Industry Pharmaceutical Preparations | 903 out of 1,329 | 32nd |
Source: SEC filing on March 20, 2018.
Guse's colleagues
We found one more compensation record of an executive who worked with Kyle Guse at Atossa Genetics in 2017.
2017
Steven Quay
Atossa Genetics
Chief Executive Officer
News
Atossa Genetics CEO Steven Quay's 2022 pay falls 46% to $3.2M
March 30, 2023
Atossa Genetics CEO Steven Quay's 2021 pay jumps 101% to $5.9M
April 11, 2022
Atossa Genetics CEO Steven Quay's 2020 pay falls 49% to $2.9M
April 15, 2021
Atossa Genetics CEO Steven Quay's 2019 pay jumps 209% to $5.8M
April 13, 2020
Atossa Genetics CEO Steven Quay's 2018 pay jumps 84% to $1.9M
April 12, 2019